Baidu
map

当心!这17类药物可引起高血压!(建议收藏)

2022-03-23 Gcplive 药评中心

药师给你提个醒,这17类药物可引起高血压!

药物性高血压是常规剂量的药物本身或该药物与其他药物之间发生相互作用而引起血压升高,当血压>140/90mmHg时即考虑药物性高血压。原则上,一旦确诊高血压与用药有关,应该尽量停用这类药物,换用其他药物或者采取降压药物治疗。

01

甘草类

图片

温馨提示:

 

前列腺素和组胺有扩血管作用。甘利欣(甘草酸二铵):主要用于伴有谷丙氨基转移酶升高的急、慢性病毒性肝炎的治疗。生胃酮(甘珀酸钠,甘草次酸的半琥珀酸酯二钠盐):用于消化性溃疡的治疗。

02

非甾体抗炎药

图片

温馨提示:

 

非甾体抗炎药可减弱降压药的作用。对于一些肾功能不全的病人,血管紧张素转换酶抑制剂与非甾体类抗炎药合用时,可能导致肾功能进一步减退。

03

噻唑烷二酮类降糖药

图片

温馨提示:

 

罗格列酮:水肿发生率为4.8%,与胰岛素合用时为15.3%。噻唑烷二酮类药物有导致或加重充血性心力衰竭的危险。

04

麻黄素类

图片

温馨提示:

 

建议高血压和心脏病患者应在医生指导下使用含麻黄的中成药。

05

β2受体激动剂

图片

温馨提示:

 

β2受体激动剂主要用于哮喘,常见不良反包括震颤、头痛、心动过速等。

06

茶碱类

图片
温馨提示:

茶碱类可致心律失常,可使原有的心律失常恶化。茶碱与麻黄碱合用可使毒性增强。克林霉素、林可霉素、红霉素、罗红霉素、克拉霉素、依诺沙星、环丙沙星、氧氟沙星等可降低茶碱清除率,增高茶碱不良反应发生率。

07

左甲状腺素

图片

温馨提示:

 

老年、有心血管疾病患者、有心肌缺血或糖尿病者,应从小剂量开始,给药后应密切观察患者有否心率加快、心律不齐、血压改变。

08

 

催产素

图片

温馨提示:

 

垂体后叶素:含催产素和加压素,主要用于肺、支气管出血(如咯血)、消化道出血(呕血、便血),并适用于产科催产及产后收缩子宫、止血等。

09

单胺氧化酶抑制剂类

图片
温馨提示:

呋喃唑酮:目前只能用于难以根除的幽门螺旋杆菌感染。利血平:北京降压0号、降压乐等传统复方降压药的成分之一。

10

抗震颤麻痹药

图片
温馨提示:

多巴丝肼是左旋多巴与盐酸苄丝肼的复方制剂,也可升高血压。

 

11

环孢素等免疫抑制剂

图片

12

促红细胞生成素

图片

13

雌激素类

图片

温馨提示:

 

倍美力(结合雌激素片);内美通(孕三烯酮胶囊);妈富隆(去氧孕烯炔雌醇片)。

14

孕激素类

图片
温馨提示:

炔诺酮:用于月经不调、子宫功能出血、子宫内膜异位症等;单方或与雌激素合用能抑制排卵,作避孕药。醋酸甲羟孕酮:可用于月经不调、功能性子宫出血及子宫内膜异位症等。还可用于子宫内膜癌、晚期乳腺癌

15

雄激素

图片

16

糖皮质激素

图片

17

麻醉药

图片

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1217142, encodeId=f736121e1423f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu May 05 19:06:17 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206297, encodeId=2e01120629e88, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Sun Mar 27 09:45:31 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205639, encodeId=cce412056390d, content=学了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Thu Mar 24 18:39:44 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205500, encodeId=47d71205500d5, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 10:15:45 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
    2022-05-05 1881eacd07m

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1217142, encodeId=f736121e1423f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu May 05 19:06:17 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206297, encodeId=2e01120629e88, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Sun Mar 27 09:45:31 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205639, encodeId=cce412056390d, content=学了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Thu Mar 24 18:39:44 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205500, encodeId=47d71205500d5, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 10:15:45 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
    2022-03-27 清漩
  3. [GetPortalCommentsPageByObjectIdResponse(id=1217142, encodeId=f736121e1423f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu May 05 19:06:17 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206297, encodeId=2e01120629e88, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Sun Mar 27 09:45:31 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205639, encodeId=cce412056390d, content=学了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Thu Mar 24 18:39:44 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205500, encodeId=47d71205500d5, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 10:15:45 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
    2022-03-24 ms9000000080461052

    学了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1217142, encodeId=f736121e1423f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu May 05 19:06:17 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206297, encodeId=2e01120629e88, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Sun Mar 27 09:45:31 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205639, encodeId=cce412056390d, content=学了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Thu Mar 24 18:39:44 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205500, encodeId=47d71205500d5, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 10:15:45 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
    2022-03-24 医路前行4231

    学习

    0

相关资讯

JAHA:高血压相关心血管疾病死亡率的县级趋势

与高血压相关的CVD死亡率在县级范围内大幅增加,这为加强临床和公共卫生行动敲响了警钟,以改善全国各县的高血压预防、检测和控制,并防止随后的CVD死亡。

Am Clin Nutrition: 亚麻荠油对患有代谢综合征的原发性高血压患者血管功能的影响

代谢综合征病因尚未明确,目前认为是多基因和多种环境相互作用的结果,与遗传、免疫等均有密切关系。

超13万人荟萃分析:这个内科超常用的药物,用超过3年或大大增加癌症,特别是肺癌发生风险!

PLOS ONE:血管紧张素受体阻滞剂的癌症风险随着累积暴露的增加而增加:随机试验的Meta回归分析。

中国人群研究:吃肉也可降血压!Hypertension教你这样摄入蛋白质,新发高血压风险降低26%!

Hypertension:不同食物来源的蛋白质种类与新发高血压的负相关关系。

中国近万人随访数据:每天刷牙≥两次,即可预防高血压和糖尿病!

J Clin Hypertens:口腔卫生与高血压和2型糖尿病的关联:中国西南地区基于人群的队列研究。

JAHA:体力活动与高血压患者死亡率和心血管疾病发病率的前瞻性关联

该研究结果强调了体育锻炼对高血压患者的重要性,并提供了新的证据来支持为这一高危人群制定体育锻炼指南建议。

Baidu
map
Baidu
map
Baidu
map